These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12222670)

  • 1. Clinical trials with hypericum extracts in patients with depression--results, comparisons, conclusions for therapy with antidepressant drugs.
    Schulz V
    Phytomedicine; 2002 Jul; 9(5):468-74. PubMed ID: 12222670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials.
    Kasper S; Dienel A
    Psychopharmacology (Berl); 2002 Nov; 164(3):301-8. PubMed ID: 12424554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression.
    Kasper S; Caraci F; Forti B; Drago F; Aguglia E
    Eur Neuropsychopharmacol; 2010 Nov; 20(11):747-65. PubMed ID: 20708905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. St. John's Wort. An option for the primary care treatment of depressive patients?
    Gupta RK; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):140-8. PubMed ID: 12904978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High dose St. John's wort extract as a phytogenic antidepressant].
    Kasper S; Schulz V
    Wien Med Wochenschr; 1999; 149(8-10):191-6. PubMed ID: 10483679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
    Randløv C; Mehlsen J; Thomsen CF; Hedman C; von Fircks H; Winther K
    Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
    Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
    BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [St John's wort against depression in favour again].
    Nordfors M; Hartvig P
    Lakartidningen; 1997 Jun; 94(25):2365-7. PubMed ID: 9229655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
    Kalb R; Trautmann-Sponsel RD; Kieser M
    Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G; Schüle C; Baghai T; Kieser M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
    Mannel M; Kuhn U; Schmidt U; Ploch M; Murck H
    J Psychiatr Res; 2010 Sep; 44(12):760-7. PubMed ID: 20181361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled clinical trials of hypericum extracts in depressed patients--an overview.
    Volz HP
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():72-6. PubMed ID: 9342763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypericum extract WS ® 5570 for depression--an overview.
    Gastpar M
    Int J Psychiatry Clin Pract; 2013 Nov; 17 Suppl 1():1-7. PubMed ID: 23808616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
    Brenner R; Azbel V; Madhusoodanan S; Pawlowska M
    Clin Ther; 2000 Apr; 22(4):411-9. PubMed ID: 10823363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.
    Singer A; Schmidt M; Hauke W; Stade K
    Phytomedicine; 2011 Jun; 18(8-9):739-42. PubMed ID: 21514125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of St. John's Wort for depression in primary care - a non-interventional study].
    Musselmann B; Rychlik R; Burkart M
    MMW Fortschr Med; 2011 Dec; 153 Suppl 4():119-27. PubMed ID: 23964473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
    Volz HP; Murck H; Kasper S; Möller HJ
    Psychopharmacology (Berl); 2002 Nov; 164(3):294-300. PubMed ID: 12424553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities.
    Laakmann G; Dienel A; Kieser M
    Phytomedicine; 1998 Dec; 5(6):435-42. PubMed ID: 23196026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial.
    Wheatley D
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():77-80. PubMed ID: 9342764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.